WANdisco secures contract with major US healthcare corporation

July 03 2017

Provider of so-called ‘active data replication’, WANdisco, announced on Monday that it secured a new contract with a "major" American healthcare corporation serving 50 million Americans in all 50 states, for the deployment of its ‘Fusion’ patented big data and cloud product.

The AIM-traded company said the contract was secured directly by WANdisco on a three year subscription licence agreement.

It said the client planned to deploy business-critical strategic patient data across a new big data/cloud infrastructure, which has “stringent requirements” around continuous availability of the applications and data.

Fusion was reportedly selected as it was seen by the client as “the only” enterprise-level solution that could transfer the large volumes of continuously-changing critical patient data to the cloud, without impacting its availability and consistency.

“We are delighted to have secured our first customer in the healthcare sector, a large and highly prized target market for our business,” said co-founder and CEO David Richards.

“We already have agreements with customers in the automotive, government, retail and finance sectors - and we believe the demand for Fusion doesn't stop there.

“What is also particularly pleasing is that to secure a contract with a healthcare business, where downtime and disruption to critical patient data is not an option, is further validation of not only our technology, but also our ability to manage unprecedented volumes of active, transactional data.”

Read more

Recent News Stories

Get Started

keyboard_arrow_down

Request a free trial and demonstration of WANdisco's products now.

Cookies and Privacy

At WANdisco, we respect your concerns about privacy and value the relationship that we have with you.

Like many companies, we use technology on our website to collect information that helps us enhance your experience and our products and services. The cookies that we use at WANdisco allow our website to work and help us to understand what information and advertising is most useful to visitors.

Please take a moment to familiarise yourself with our cookie practices and let us know if you have any questions by getting in touch through any of the methods listed on our "Contact Us" page.

We have tried to keep this Notice as simple as possible, but if you’re not familiar with terms, such as cookies, IP addresses, and browsers, then read about these key terms first.